Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.

Fluoroquinolone resistance in a clinical isolate of Streptococcus pneumoniae in the South Pacific.

Le Hello S, Page S, Garin B.

Int J Antimicrob Agents. 2008 Jul;32(1):91-2. doi: 10.1016/j.ijantimicag.2008.02.015. No abstract available.

PMID:
18495439
2.

Molecular characterization of genes encoding the quinolone resistance determining regions of Malaysian Streptococcus pneumoniae strains.

Kumari N, Subramaniam G, Navaratnam P, Sekaran SD.

Indian J Med Microbiol. 2008 Apr-Jun;26(2):148-50.

3.

Emergence of high-level fluoroquinolone-resistant Streptococcus pneumoniae in Turkey.

Ak O O, Benzonana N, Ozer S, Eraksoy H.

Int J Infect Dis. 2003 Dec;7(4):288-9. No abstract available.

PMID:
14656422
4.
5.

Stability of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived mutants.

Smith-Adam HJ, Nichol KA, Hoban DJ, Zhanel GG.

Antimicrob Agents Chemother. 2005 Feb;49(2):846-8.

6.

Epidemiology of antibiotic-resistant Streptococcus pneumoniae strains in Far East Russia.

Martynova AV, Turcutyuicov VB.

Int J Antimicrob Agents. 2004 Jun;23(6):641-2. No abstract available.

PMID:
15194139
8.

Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae.

El Garch F, Lismond A, Piddock LJ, Courvalin P, Tulkens PM, Van Bambeke F.

J Antimicrob Chemother. 2010 Oct;65(10):2076-82. doi: 10.1093/jac/dkq287. Erratum in: J Antimicrob Chemother. 2011 Jun;66(6):1414-5.

9.

Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae.

Schurek KN, Adam HJ, Hoban DJ, Zhanel GG.

Int J Antimicrob Agents. 2006 Sep;28(3):266-9.

PMID:
16904294
10.

Fluoroquinolone-resistant Streptococcus pneumoniae.

Pletz MW, Fugit RV, McGee L, Glasheen JJ, Keller DL, Welte T, Klugman KP.

Emerg Infect Dis. 2006 Sep;12(9):1462-3. No abstract available.

11.
12.

Fluoroquinolone-resistant pneumococci: maybe resistance isn't futile?

Low DE.

Clin Infect Dis. 2005 Jan 15;40(2):236-8. No abstract available.

13.

Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.

Adam HJ, Hoban DJ, Gin AS, Zhanel GG.

Int J Antimicrob Agents. 2009 Jul;34(1):82-5. doi: 10.1016/j.ijantimicag.2009.02.002.

PMID:
19342204
14.

Erythromycin resistance caused by erm(A) subclass erm(TR) in a Danish invasive pneumococcal isolate: are erm(A) pneumococcal isolates overlooked?

Lambertsen L, Ekelund K, Hansen DS, Kaltoft M, Christensen JJ, Hammerum AM.

Scand J Infect Dis. 2008;40(6-7):584-7. doi: 10.1080/00365540701854717.

PMID:
18584554
15.

Molecular characterization of high-level fluoroquinolone resistance in a clinical isolate of Haemophilus parainfluenzae.

Rodríguez-Martínez JM, López-Hernández I, Pascual A.

J Antimicrob Chemother. 2011 Mar;66(3):673-5. doi: 10.1093/jac/dkq473. No abstract available.

16.
17.

In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease.

Pérez-Trallero E, Marimón JM, González A, Ercibengoa M, Larruskain J.

Clin Infect Dis. 2005 Aug 15;41(4):560-4.

18.

Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics.

Feldman C, Brink AJ, von Gottberg A, Wolter N, de Gouveia L, Perovic O, Klugman KP.

Int J Antimicrob Agents. 2010 Jul;36(1):95-7. doi: 10.1016/j.ijantimicag.2010.02.021. No abstract available.

PMID:
20378315
19.
20.

The first steps towards fluoroquinolone resistance in Hungarian pneumococci.

Dobay O, Rozgonyi F, Ghidán A, Matuz M, Nagy K, Amyes SG.

J Chemother. 2006 Dec;18(6):624-7.

PMID:
17267340
Items per page

Supplemental Content

Support Center